共 7 条
[1]
PRIMARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION:A QUANTITATIVE REVIEW OF23RANDOMIZED TRIALS. KEELEY EC,BOURA JA,GRINES CL. The Lancet . 2003
[2]
INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL INFARCTION:COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMISED TRIALS OF MORE THAN1000PATIENTS. FIBRINOLYTIC THERAPY TRIALISTS′(FTT)COLLABORATIVE GROUP. The Lancet . 1994
[3]
CORONARY ANGIOPLASTY WITH ORWITHOUT STENT IMPLANTATION FOR ACUTE MYOCARDIAL INFARCTION. GRINES CI,COX DA,STONE GW,ET AL. The New England Journal of Medicine . 1999
[4]
RANDOMIZED COMPARISON OF CORONARY STENTING WITH BALLOON ANGIOPLASTY IN SELECTED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. SURYAPRANATA H,VAN′T HOF AW,HOORNT JC,ET AL. Circulation . 1998
[5]
RANDOMIZED COMPARISON OF RESCUE ANGIOPLASTY WITH CONSERVATIVE MANAGEMENT OF PATIENTS WITH EARLY FAILURE OF THROMBOLYSIS FOR ACUTE ANTERIOR MYOCARDIAL INFARCTION. ELLIS SG,RIBERIERO DA SILVA E,HEYNDRICKX G,ET AL. Circulation . 1994
[6]
SYMPTOM-ONSET-TO-BALLOON TIME AND MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED BY PRIMARY ANGIOPLASTY. DE LUCA G,SURYAPRANATA H,ZIJLSTRA F,ET AL. Journal of the American College of Cardiology . 2003
[7]
IMPACT OF TIME TO TREATMENT ON MORTALITY AFTER PROHOSPITAL FIBRINOLYSIS OR PRIMARY ANGIOPLASTY.DATA FROM THE CAPTIMRANDOMIZED CLINICAL TRIAL. STEG PG,BONNEFOY E,CHABAND S,ET AL. Circulation . 2003